Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1175924

	registered interest
	date	04/02/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Smoking
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether the Tobacco Control Plan 2017-2022 is making adequate progress to reduce adult smoking prevalence to 12 per cent by 2022.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	12227
	answer	answer is ministerial correction date of answer 10/02/2020 answer text <p>Adult smoking rates in England are at their lowest level recorded at 14.4% of the population. The Government continues to make progress towards delivering the ambition of 12% or less by the end of 2022. As announced in the Prevention Green Paper the Government has set out a further ambition to go ‘smoke-free’ in England by 2030. Proposals for this will be set out at a later date.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 10/02/2020 16:55:41 answering member 4380 label Biography information for Jo Churchill
	tabling member	1409 label Biography information for Mr Gregory Campbell

1176328

	registered interest
	date	05/02/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Colposcopy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what changes the NHS is making to (a) the management of CIN 2 cervical cell changes and (b) other aspects of colposcopy and programme management.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	12844
	answer	answer is ministerial correction date of answer 10/02/2020 answer text <p>The National Health Service Cervical Screening Programme (NHS CSP) published its programme and colposcopy management guidance on 5 February 2020. This can be viewed at the following link:</p><p><a href="https://www.gov.uk/government/publications/cervical-screening-programme-and-colposcopy-management" target="_blank">https://www.gov.uk/government/publications/cervical-screening-programme-and-colposcopy-management</a></p><p>This includes guidance on policy, management and referral for colposcopy, providing a quality colposcopy clinic as well as colposcopic diagnosis treatment and follow up. In addition, there is a new section on conservative management for cervical intraepithelial neoplasia (CIN 2) cell changes and other aspects of colposcopy and programme management. This can be viewed at the following link:</p><p><a href="https://www.gov.uk/government/publications/cervical-screening-programme-and-colposcopy-management/3-colposcopic-diagnosis-treatment-and-follow-up" target="_blank">https://www.gov.uk/government/publications/cervical-screening-programme-and-colposcopy-management/3-colposcopic-diagnosis-treatment-and-follow-up</a></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 10/02/2020 17:56:41 answering member 4380 label Biography information for Jo Churchill
	tabling member	1409 label Biography information for Mr Gregory Campbell

1177084

	registered interest
	date	07/02/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Diagnosis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the news story entitled, Early cancer detection and survival to be prioritised by NHS, published by his Department in July 2019, if he will make it his policy to publish regular progress reports on the Government's ambition for three-quarters of all cancers to be detected at an early stage by 2028.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	13945
	answer	answer is ministerial correction date of answer 12/02/2020 answer text <p>The National Cancer Registration and Analysis Service (NCRAS) are currently developing a new early diagnosis metric which will be used specifically to track progress towards the 75% ambition. This new metric will provide a more comprehensive measure of early diagnosis, including more cancer sites than the current available measures.</p><p>This metric will be regularly reported on the NCRAS website.</p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 12/02/2020 17:26:37 answering member 4380 label Biography information for Jo Churchill
	tabling member	1409 label Biography information for Mr Gregory Campbell

1177521

	registered interest
	date	10/02/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	MMR Vaccine
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of trends in the uptake of the measles, mumps and rubella vaccine in the last five years.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	14630
	answer	answer is ministerial correction date of answer 13/02/2020 answer text <p>Between 2013/14 and 2018/19 coverage for one Measles, Mumps and Rubella (MMR) vaccine dose at 24 months decreased 2.4% points from 92.7% to 90.3%. Coverage for two doses, at five years of age, decreased 1.9% points from 88.3% in 2013/14 to 86.4% in 2018/19. Coverage of the first dose by five years of age in England has been more or less stable from 2015 to 2018 reaching the World Health Organization’s target level of 95% for the first-time in 2016-17 but dropping to 94.9% in 2017-18.</p><p> </p><p>The following table shows uptake of the MMR vaccine at first dose at 24 months and in five year olds, and second dose in five year olds in England since 2013/14.</p><p> </p><table><tbody><tr><td><p>-</p></td><td><p>24 months</p></td><td><p>Five years</p></td><td><p>Five years</p></td></tr><tr><td><p>-</p></td><td><p>% MMR (1st Dose)</p></td><td><p>% MMR (1st Dose)</p></td><td><p>% MMR (1st and 2nd Dose)</p></td></tr><tr><td><p>2013-14</p></td><td><p>92.7</p></td><td><p>94.1</p></td><td><p>88.3</p></td></tr><tr><td><p>2014-15</p></td><td><p>92.3</p></td><td><p>94.4</p></td><td><p>88.6</p></td></tr><tr><td><p>2015-16</p></td><td><p>91.9</p></td><td><p>94.8</p></td><td><p>88.2</p></td></tr><tr><td><p>2016-17</p></td><td><p>91.6</p></td><td><p>95.0</p></td><td><p>87.6</p></td></tr><tr><td><p>2017-18</p></td><td><p>91.2</p></td><td><p>94.9</p></td><td><p>87.2</p></td></tr><tr><td><p>2018-19</p></td><td><p>90.3</p></td><td><p>94.5</p></td><td><p>86.4</p></td></tr></tbody></table><p>Source:</p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/nhs-immunisation-statistics/england-2018-19" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/nhs-immunisation-statistics/england-2018-19</a></p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 13/02/2020 17:03:51 answering member 4380 label Biography information for Jo Churchill
	tabling member	1409 label Biography information for Mr Gregory Campbell

1177996

	registered interest
	date	12/02/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Niraparib
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what progress he has made on increasing the availability of the ovarian cancer drug Zejula.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	1173
	answer	answer is ministerial correction date of answer 24/02/2020 answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based recommendations on whether new medicines represent value for money for the National Health Service in England.</p><p>NICE may recommend promising new cancer drugs for use in the Cancer Drugs Fund (CDF) where there is potential for the drug to be considered for routine commissioning but there is significant remaining clinical uncertainty which needs more investigation through data collection in the NHS or clinical trials.</p><p>In July 2018 NICE published guidance recommending niraparib (brand name Zejula) for use within the CDF as an option for treating relapsed, platinum-sensitive high-grade serious epithelial ovarian, fallopian tube, or primary peritoneal cancer, that has responded to the most recent course of platinum-based chemotherapy in adults who have had two or more courses of platinum-based chemotherapy. Niraparib is now available to NHS patients through the CDF in line with this guidance.</p><p>In March 2019, the Department asked NICE to conduct an appraisal of niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy. NICE expects to publish final guidance in February 2021.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 24/02/2020 17:05:15 answering member 4380 label Biography information for Jo Churchill
	tabling member	1409 label Biography information for Mr Gregory Campbell

1178619

	registered interest
	date	11/02/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment the National Supply Disruption Response has made of the potential risk to supplies of essential medicines in the next two years.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	14964
	answer	answer is ministerial correction date of answer 24/02/2020 answer text <p>The Department assesses the potential risk to the supply of medicines on an ongoing basis. It is not the role of the National Supply Disruption Response to provide an ongoing assessment of the potential risk to the supply of medicines.</p><p>Where we are aware of a potential risk, the Department’s Medicine Supply team works closely with the Medicines and Healthcare products Regulatory Authority, the pharmaceutical industry, the National Health Service and others operating in the supply chain to help prevent shortages and to ensure that the risks to patients are minimised when they do arise.</p><p>In addition to this, marketing authorisation holders of United Kingdom licensed medicines are required under the Health Service Products Regulations 2018 to notify the Department if they are aware of an impending supply shortage of a medicine at least six months prior to the shortage or, if not possible, as soon as reasonably practicable.</p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 24/02/2020 17:06:55 answering member 4380 label Biography information for Jo Churchill
	tabling member	1409 label Biography information for Mr Gregory Campbell

1180324

	registered interest
	date	25/02/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prostate Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the timetable is for the National Screening Committee to conduct the next review of the evidence on screening for prostate cancer.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	20399
	answer	answer is ministerial correction date of answer 02/03/2020 answer text <p>Screening for prostate cancer forms part of the United Kingdom National Screening Committee’s 2019/20 work plan. A three-month public consultation will take place in summer 2020 where a recommendation will be made for the screening of prostate cancer.</p><p>Further information and how to participate in the consultation is available at the following link:</p><p><a href="https://legacyscreening.phe.org.uk/screening-recommendations.php" target="_blank">https://legacyscreening.phe.org.uk/screening-recommendations.php</a></p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 02/03/2020 15:27:53 answering member 4380 label Biography information for Jo Churchill
	tabling member	1409 label Biography information for Mr Gregory Campbell

1183781

	registered interest
	date	09/03/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Smoking: Pregnancy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the current prevalence rate of women smoking during pregnancy; and what assessment he has made of the likelihood of reducing that prevalence to 6 per cent by the end of 2022.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	26821
	answer	answer is ministerial correction date of answer 12/03/2020 answer text <p>In 2018/19 the prevalence of smoking in pregnant women was 10.6%.</p><p>The Government has a track record of reducing the harms caused by tobacco and is committed to achieving its ambition to reduce smoking in pregnancy to 6% or less by 2022.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 12/03/2020 12:53:57 answering member 4380 label Biography information for Jo Churchill
	tabling member	1409 label Biography information for Mr Gregory Campbell

1185877

	registered interest
	date	17/03/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Alcoholic Drinks
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what preparations he is making to tackle the potential increase in domestic alcohol abuse as a result of reduced social interaction during the covid-19 outbreak.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	30689
	answer	answer is ministerial correction date of answer 28/04/2020 answer text <p>The Government provides advice on the importance of drinking in moderation. This can be found through the One You service and at the following link:</p><p><a href="https://www.nhs.uk/live-well/alcohol-support/the-risks-of-drinking-too-much" target="_blank">https://www.nhs.uk/live-well/alcohol-support/the-risks-of-drinking-too-much</a></p><p>The 2016 UK Chief Medical Officers’ low risk drinking guidelines also provide the public with the most up to date information to help people make informed decisions about their own drinking.</p><p>Local authorities are responsible for assessing local needs and commissioning alcohol prevention, treatment and harm reduction services to meet these needs. It is important that these services are maintained during the COVID-19 pandemic. Guidance to support commissioners and providers of services for people who use alcohol during the COVID-19 pandemic has been published and is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/covid-19-guidance-for-commissioners-and-providers-of-services-for-people-who-use-drugs-or-alcohol/covid-19-guidance-for-commissioners-and-providers-of-services-for-people-who-use-drugs-or-alcohol" target="_blank">https://www.gov.uk/government/publications/covid-19-guidance-for-commissioners-and-providers-of-services-for-people-who-use-drugs-or-alcohol/covid-19-guidance-for-commissioners-and-providers-of-services-for-people-who-use-drugs-or-alcohol</a></p><p>Additionally, a Clinical Speciality guide for the management of people with alcohol dependence during the COVID-19 pandemic was published on 8 April and is available at the following link:</p><p><a href="https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/04/C0157-Specialty-guide_-Alcohol-Dependence-and-coronavirus_8-April.pdf" target="_blank">https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/04/C0157-Specialty-guide_-Alcohol-Dependence-and-coronavirus_8-April.pdf</a></p><p> </p><p>Guidance to support alcohol-dependent drinkers to reduce their intake in a managed way will be published shortly.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 28/04/2020 16:14:50 answering member 4380 label Biography information for Jo Churchill previous answer version 13983 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
	tabling member	1409 label Biography information for Mr Gregory Campbell

1186434

	registered interest
	date	19/03/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	MMR Vaccine
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps is he taking to improve take-up of the MMR vaccine for five year old children.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	32069
	answer	answer is ministerial correction date of answer 25/03/2020 answer text <p>To increase take-up of the measles, mumps and rubella (MMR) vaccine, NHS England and NHS Improvement and Public Health England are working with key regional and local stakeholders, such as Directors of clinical quality, clinical commissioning groups and local authorities, to implement actions from Public Health England’s ‘Measles and rubella UK elimination strategy 2019’. The actions include notifications from Child Health Information Services to help general practices identify children with due and overdue vaccinations and improving information to parents that emphasises the importance getting the MMR vaccination.</p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 25/03/2020 16:02:45 answering member 4380 label Biography information for Jo Churchill previous answer version 14526 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
	tabling member	1409 label Biography information for Mr Gregory Campbell